. 2016 Nov 15;5(11):e387. doi: 10.1038/mtna.2016.96
Copyright © 2016 Official journal of the American Society of Gene & Cell Therapy
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
Table 2. Influence of miR-9600 expression and clinical characteristics on overall survival in NSCLC patients.
